Company · CIK 0000842023 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
BIO-TECHNE Corp · TECH
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 FMForm 4 → | Sep 24, 4:52 pm EDT | Robert V BaumgartnerDirector | 21,499 | $72.55 | $403,305 | 56,884 | — | |
| Aug 15, 2026 FMForm 4 → | Aug 18, 5:14 pm EDT | Kim KeldermanChief Executive Officer, Director | 32,291 | $72.40 | $783,440 | 82,762 | — | |
| Aug 15, 2026 FMForm 4 → | Aug 18, 5:13 pm EDT | James HippelCFO | 14,089 | $72.40 | $312,044 | 170,183 | — | |
| Aug 15, 2026 FMForm 4 → | Aug 18, 5:13 pm EDT | William GeistPRESIDENT, PROTEIN SCIENCES | 8,392 | $72.40 | $143,062 | 24,943 | — | |
| Aug 15, 2026 FMForm 4 → | Aug 18, 4:42 pm EDT | Shane BohnenSVP - General Counsel | 5,693 | $72.40 | $97,233 | 10,360 | — | |
| Aug 15, 2026 FMForm 4 → | Aug 18, 4:13 pm EDT | Steven C. CrousePresident - Diag & Spatial Bi | 7,370 | $72.40 | $140,963 | 10,237 | — | |
| Aug 15, 2026 FMForm 4 → | Aug 18, 4:12 pm EDT | Amy E. HerrDirector | 802 | $72.40 | $15,421 | 576 | — | |
| Jul 29, 2026 FMForm 4 → | Jul 31, 5:18 pm EDT | James HippelCFO | 113,092 | $58.62 | $6,629,696 | 164,714 | — | |
| Jul 28, 2026 FMForm 4 → | Jul 30, 4:11 pm EDT | Kim KeldermanChief Executive Officer, Director | 63,686 | $58.62 | $3,733,400 | 72,113 | — | |
| Jul 23, 2026 FMForm 4 → | Jul 27, 4:03 pm EDT | Shane BohnenSVP - General Counsel | 792 | $58.10 | $46,014 | 7,353 | — | |
| Jun 2, 2026 FMForm 4 → | Jun 4, 4:28 pm EDT | Steven C. CrousePresident - Diag & Spatial Bi | 816 | $49.77 | $10,750 | 6,761 | — | |
| Oct 25, 2018 AForm 4 → | Oct 29, 5:09 pm EDT | Randolph C SteerDirector | 514 | — | — | 4,226 | — | plan? |
| Oct 25, 2018 AForm 4 → | Oct 29, 5:07 pm EDT | Alpna SethDirector | 514 | — | — | 1,253 | — | plan? |
| Oct 25, 2018 AForm 4 → | Oct 29, 5:02 pm EDT | Harold J WiensDirector | 514 | — | — | 4,726 | — | plan? |
| Oct 25, 2018 AForm 4 → | Oct 29, 5:00 pm EDT | Roeland NusseDirector | 514 | — | — | 5,226 | — | plan? |
| Oct 25, 2018 AForm 4 → | Oct 29, 4:57 pm EDT | Joseph D KeeganDirector | 514 | — | — | 1,253 | — | plan? |
| Oct 25, 2018 AForm 4 → | Oct 29, 4:54 pm EDT | John L HigginsDirector | 514 | — | — | 3,526 | — | plan? |
| Oct 25, 2018 AForm 4 → | Oct 29, 4:51 pm EDT | Robert V BaumgartnerDirector | 514 | — | — | 8,226 | — | plan? |
| Aug 24, 2018 SForm 4 → | Aug 28, 5:30 pm EDT | Robert V BaumgartnerDirector | 5,000 | $188.47 | $942,334 | 7,712 | −39.3% | plan? |
| Aug 24, 2018 MForm 4 → | Aug 28, 5:30 pm EDT | Robert V BaumgartnerDirector | 5,000 | $61.46 | $307,300 | 12,712 | — | plan? |
| Aug 23, 2018 SForm 4 → | Aug 27, 4:12 pm EDT | John L HigginsDirector | 10,000 | $187.92 | $1,879,173 | 3,012 | −76.9% | plan? |
| Aug 23, 2018 MForm 4 → | Aug 27, 4:12 pm EDT | John L HigginsDirector | 10,000 | $61.08 | $610,800 | 13,012 | — | plan? |
| Aug 18, 2018 FForm 4 → | Aug 31, 4:39 pm EDT | Charles R. KummethChief Executive Officer, Director | 1,338 | $180.50 | $241,509 | 92,176 | — | plan? late |
| Aug 8, 2018 SForm 4 → | Aug 10, 4:18 pm EDT | Charles A DinarelloDirector | 5,000 | $176.94 | $884,675 | 8,212 | −37.8% | plan? |
| Aug 8, 2018 MForm 4 → | Aug 10, 4:18 pm EDT | Charles A DinarelloDirector | 5,000 | $63.03 | $315,150 | 13,212 | — | plan? |
| Aug 7, 2018 AFMForm 4 → | Aug 9, 7:22 pm EDT | Charles R. KummethChief Executive Officer, Director | 33,148 | $180.14 | $1,450,667 | 93,514 | — | plan? |
| Aug 7, 2018 FMForm 4 → | Aug 9, 6:29 pm EDT | Norman David EansorSVP - Novus Biologicals | 1,547 | $180.14 | $62,689 | 3,117 | — | plan? |
| Aug 7, 2018 FMForm 4 → | Aug 9, 6:26 pm EDT | Brenda S. FurlowSVP - General Counsel | 1,397 | $180.14 | $78,901 | 2,189 | — | plan? |
| Aug 7, 2018 FMForm 4 → | Aug 9, 6:19 pm EDT | James HippelChief Financial Officer | 3,492 | $180.14 | $197,073 | 4,382 | — | plan? |
| Jun 7, 2018 SForm 4 → | Jun 8, 4:21 pm EDT | Charles R. KummethChief Executive Officer, Director | 8,000 | $160.00 | $1,280,000 | 76,472 | −9.47% | plan? |
| May 4, 2018 SForm 4 → | May 11, 4:16 pm EDT | Norman David EansorSVP - Novus Biologicals | 1,136 | $145.19 | $164,932 | 2,266 | −33.4% | plan? late |
| Feb 13, 2018 SForm 4 → | Feb 15, 4:02 pm EST | Charles A DinarelloDirector | 5,000 | $136.06 | $680,303 | 8,212 | −37.8% | plan? |
| Feb 13, 2018 MForm 4 → | Feb 15, 4:02 pm EST | Charles A DinarelloDirector | 5,000 | $65.47 | $327,350 | 13,212 | — | plan? |
| Nov 1, 2017 SForm 4 → | Nov 3, 4:41 pm EDT | Robert V BaumgartnerDirector | 5,000 | $130.18 | $650,907 | 7,712 | −39.3% | plan? |
| Nov 1, 2017 MForm 4 → | Nov 3, 4:41 pm EDT | Robert V BaumgartnerDirector | 5,000 | $63.03 | $315,150 | 12,712 | — | plan? |
| Oct 26, 2017 AForm 4 → | Oct 31, 11:37 am EDT | Joseph D KeeganDirector | 739 | — | — | 739 | — | plan? late |
| Oct 26, 2017 AForm 4 → | Oct 30, 5:16 pm EDT | Charles R. KummethChief Executive Officer, Director | 14,194 | — | — | 84,472 | — | plan? |
| Oct 26, 2017 AForm 4 → | Oct 30, 5:14 pm EDT | Alpna SethDirector | 739 | — | — | 739 | — | plan? |
| Oct 26, 2017 AForm 4 → | Oct 30, 5:10 pm EDT | Randolph C SteerDirector | 739 | — | — | 3,712 | — | plan? |
| Oct 26, 2017 AForm 4 → | Oct 30, 5:03 pm EDT | Robert V BaumgartnerDirector | 739 | — | — | 7,712 | — | plan? |
| Oct 26, 2017 AForm 4 → | Oct 30, 4:54 pm EDT | John L HigginsDirector | 739 | — | — | 3,012 | — | plan? |
| Oct 26, 2017 AForm 4 → | Oct 30, 4:53 pm EDT | Roeland NusseDirector | 739 | — | — | 4,712 | — | plan? |
| Oct 26, 2017 AForm 4 → | Oct 30, 4:50 pm EDT | Harold J WiensDirector | 739 | — | — | 4,212 | — | plan? |
| Oct 26, 2017 AForm 4 → | Oct 30, 4:46 pm EDT | Charles A DinarelloDirector | 739 | — | — | 8,212 | — | plan? |
| Oct 10, 2017 SForm 4 → | Oct 12, 4:24 pm EDT | Roger C LucasDirector | 100 | $121.96 | $12,196 | 1,870 | −5.08% | plan? |
| Sep 8, 2017 SForm 4 → | Sep 12, 5:02 pm EDT | Roger C LucasDirector | 100 | $120.94 | $12,094 | 1,970 | −4.83% | plan? |
| Sep 6, 2017 SForm 4 → | Sep 8, 4:44 pm EDT | Karen A HolbrookDirector | 1,059 | $121.73 | $128,909 | 914 | −53.7% | plan? |
| Aug 12, 2017 MForm 4 → | Aug 15, 4:44 pm EDT | Charles R. KummethChief Executive Officer, Director | 9,248 | — | — | 70,278 | — | plan? |
| Aug 10, 2017 SForm 4 → | Aug 14, 4:24 pm EDT | Roger C LucasDirector | 100 | $114.30 | $11,430 | 2,070 | −4.61% | plan? |
| Jul 10, 2017 SForm 4 → | Jul 12, 4:34 pm EDT | Roger C LucasDirector | 100 | $116.86 | $11,686 | 2,170 | −4.41% | plan? |
| Jul 9, 2017 FForm 4 → | Jul 11, 5:30 pm EDT | Kevin S GouldSVP Clinical Controls | 312 | $117.68 | $36,716 | 1,355 | — | plan? |
| Jul 1, 2017 FForm 4 → | Jul 5, 5:53 pm EDT | Brenda S. FurlowSVP - General Counsel | 278 | $117.50 | $32,665 | 1,668 | — | plan? |
| Jul 1, 2017 FForm 4 → | Jul 5, 5:46 pm EDT | Norman David EansorSVP - Novus Biologicals | 534 | $117.50 | $62,745 | 3,402 | — | plan? |
| Jun 9, 2017 SForm 4 → | Jun 13, 4:56 pm EDT | Roger C LucasDirector | 100 | $113.62 | $11,362 | 2,270 | −4.22% | plan? |
| May 31, 2017 SForm 4 → | May 31, 4:58 pm EDT | Charles A DinarelloDirector | 5,000 | $111.37 | $556,862 | 7,473 | −40.1% | plan? |
| May 26, 2017 MForm 4 → | May 31, 4:58 pm EDT | Charles A DinarelloDirector | 5,000 | $66.59 | $332,950 | 12,473 | — | plan? |
| May 25, 2017 SForm 4 → | May 30, 4:34 pm EDT | Karen A HolbrookDirector | 5,000 | $111.15 | $555,773 | 1,973 | −71.7% | plan? |
| May 25, 2017 MForm 4 → | May 30, 4:34 pm EDT | Karen A HolbrookDirector | 5,000 | $66.59 | $332,950 | 6,973 | — | plan? |
| May 22, 2017 SForm 4 → | Jun 1, 4:51 pm EDT | Roger C LucasDirector | 1,059 | $110.01 | $116,505 | 2,370 | −30.9% | plan? late |
| May 10, 2017 SForm 4 → | May 12, 4:16 pm EDT | Roger C LucasDirector | 100 | $110.59 | $11,059 | 3,429 | −2.83% | plan? |
| Apr 10, 2017 SForm 4 → | Apr 12, 4:52 pm EDT | Roger C LucasDirector | 100 | $101.15 | $10,115 | 3,551 | −2.74% | plan? |
| Mar 31, 2017 FForm 4 → | Apr 4, 6:20 pm EDT | James HippelChief Financial Officer | 800 | $101.65 | $81,320 | 3,079 | — | plan? |
| Mar 10, 2017 SForm 4 → | Mar 14, 4:43 pm EDT | Roger C LucasDirector | 100 | $107.77 | $10,777 | 3,629 | −2.68% | plan? |
| Feb 10, 2017 SForm 4 → | Feb 14, 5:03 pm EST | Roger C LucasDirector | 100 | $102.60 | $10,260 | 3,729 | −2.61% | plan? |
| Feb 1, 2017 MForm 4 → | Feb 3, 6:54 pm EST | Robert M. GavinSenior V.P. Protein Platforms | 1,667 | — | — | 1,667 | — | plan? |
| Jan 10, 2017 SForm 4 → | Jan 12, 5:02 pm EST | Roger C LucasDirector | 100 | $103.57 | $10,357 | 3,829 | −2.55% | plan? |
| Dec 9, 2016 SForm 4 → | Dec 13, 4:31 pm EST | Roger C LucasDirector | 100 | $108.92 | $10,892 | 3,929 | −2.48% | plan? |
| Nov 29, 2016 SForm 4 → | Dec 1, 4:30 pm EST | Karen A HolbrookDirector | 1,000 | $106.73 | $106,733 | 1,973 | −33.6% | plan? |
| Nov 16, 2016 SForm 4 → | Nov 18, 4:33 pm EST | Roger C LucasDirector | 100 | $105.75 | $10,575 | 4,029 | −2.42% | plan? |
| Oct 27, 2016 AForm 4 → | Oct 31, 5:10 pm EDT | Roger C LucasDirector | 914 | — | — | 4,129 | — | plan? |
| Oct 27, 2016 AForm 4 → | Oct 31, 4:55 pm EDT | Robert V BaumgartnerDirector | 914 | — | — | 6,973 | — | plan? |
| Oct 27, 2016 AForm 4 → | Oct 31, 4:18 pm EDT | Harold J WiensDirector | 914 | — | — | 3,473 | — | plan? |
| Oct 27, 2016 AForm 4 → | Oct 31, 4:17 pm EDT | Roeland NusseDirector | 914 | — | — | 3,973 | — | plan? |
| Oct 27, 2016 AForm 4 → | Oct 31, 4:17 pm EDT | John L HigginsDirector | 914 | — | — | 2,273 | — | plan? |
| Oct 27, 2016 AForm 4 → | Oct 31, 4:17 pm EDT | Karen A HolbrookDirector | 914 | — | — | 2,973 | — | plan? |
| Oct 27, 2016 AForm 4 → | Oct 31, 4:16 pm EDT | Charles A DinarelloDirector | 914 | — | — | 7,473 | — | plan? |
| Oct 27, 2016 AForm 4 → | Oct 31, 4:16 pm EDT | Randolph C SteerDirector | 914 | — | — | 2,973 | — | plan? |
| Oct 19, 2016 SForm 4 → | Oct 31, 5:10 pm EDT | Roger C LucasDirector | 100 | $104.71 | $10,471 | 3,215 | −3.02% | plan? late |
| Sep 21, 2016 SForm 4 → | Sep 23, 4:40 pm EDT | Roger C LucasDirector | 100 | $108.91 | $10,891 | 3,315 | −2.93% | plan? |
| Sep 8, 2016 SForm 4 → | Sep 12, 5:27 pm EDT | Kevin S GouldSVP Clinical Controls | 524 | $110.50 | $57,904 | 1,667 | −23.9% | plan? |
| Sep 8, 2016 SForm 4 → | Sep 12, 5:27 pm EDT | John L HigginsDirector | 1,700 | $109.83 | $186,716 | 1,359 | −55.6% | plan? |
| Sep 1, 2016 SForm 4 → | Sep 6, 4:36 pm EDT | Robert V BaumgartnerDirector | 6,467 | $107.17 | $693,039 | 6,059 | −51.6% | plan? |
| Sep 1, 2016 MForm 4 → | Sep 6, 4:36 pm EDT | Robert V BaumgartnerDirector | 6,467 | $65.72 | $425,038 | 8,672 | — | plan? |
| Aug 24, 2016 SForm 4 → | Aug 26, 5:38 pm EDT | Robert V BaumgartnerDirector | 3,533 | $107.10 | $378,378 | 6,059 | −36.8% | plan? |
| Aug 24, 2016 MForm 4 → | Aug 26, 5:38 pm EDT | Robert V BaumgartnerDirector | 3,533 | $66.59 | $235,262 | 9,592 | — | plan? |
| Aug 18, 2016 AForm 4 → | Aug 22, 5:11 pm EDT | Charles R. KummethChief Executive Officer, Director | 16,653 | — | — | 61,030 | — | plan? |
| Aug 17, 2016 SForm 4 → | Aug 19, 4:58 pm EDT | Roger C LucasDirector | 100 | $113.70 | $11,370 | 3,415 | −2.84% | plan? |
| Jul 20, 2016 SForm 4 → | Jul 21, 11:50 am EDT | Roger C LucasDirector | 100 | $111.03 | $11,103 | 3,615 | −2.69% | plan? |
| Jul 9, 2016 FForm 4 → | Jul 12, 5:33 pm EDT | Kevin S GouldSVP Clinical Controls | 309 | $115.17 | $35,588 | 2,191 | — | plan? |
| Jul 1, 2016 FForm 4 → | Jul 6, 5:11 pm EDT | Brenda S. FurlowSVP - General Counsel | 277 | $112.24 | $31,090 | 1,946 | — | plan? |
| Jul 1, 2016 FForm 4 → | Jul 6, 5:11 pm EDT | Norman David EansorSVP - Novus Biologicals | 533 | $112.24 | $59,824 | 3,936 | — | plan? |
| Jun 15, 2016 SForm 4 → | Jun 16, 12:27 pm EDT | Roger C LucasDirector | 100 | $112.15 | $11,215 | 3,715 | −2.62% | plan? |
| May 18, 2016 SForm 4 → | May 19, 3:47 pm EDT | Roger C LucasDirector | 100 | $102.53 | $10,253 | 3,815 | −2.55% | plan? |
| May 9, 2016 SForm 4 → | May 10, 5:43 pm EDT | Charles A DinarelloDirector | 5,000 | $101.91 | $509,550 | 6,559 | −43.3% | plan? |
| May 6, 2016 SForm 4 → | May 9, 2:14 pm EDT | Roger C LucasDirector | 500 | $100.24 | $50,120 | 3,915 | −11.3% | plan? |
| May 5, 2016 MForm 4 → | May 9, 2:14 pm EDT | Charles A DinarelloDirector | 5,000 | $56.17 | $280,850 | 11,559 | — | plan? |
| Apr 20, 2016 SForm 4 → | Apr 22, 4:06 pm EDT | Roger C LucasDirector | 100 | $92.40 | $9,240 | 4,315 | −2.27% | plan? |
| Mar 31, 2016 FMForm 4 → | Apr 4, 2:57 pm EDT | James HippelChief Financial Officer | 2,222 | $94.52 | $52,553 | 5,544 | — | plan? |
| Mar 16, 2016 SForm 4 → | Mar 18, 1:03 pm EDT | Roger C LucasDirector | 100 | $92.90 | $9,290 | 4,415 | −2.21% | plan? |
| Feb 5, 2016 SForm 4 → | Feb 8, 5:48 pm EST | Roger C LucasDirector | 5,000 | $83.68 | $418,400 | 4,515 | −52.5% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 MForm 4 → | Sep 24, 4:52 pm EDT | Robert V BaumgartnerDirector | 15,940 | — | — | 0 | — | |
| Aug 17, 2026 AForm 4 → | Aug 19, 4:49 pm EDT | Shane BohnenSVP - General Counsel | 29,776 | — | — | 18,432 | — | |
| Aug 17, 2026 AForm 4 → | Aug 19, 4:48 pm EDT | Kim KeldermanChief Executive Officer, Director | 151,172 | — | — | 93,582 | — | |
| Aug 17, 2026 AForm 4 → | Aug 19, 4:48 pm EDT | James HippelCFO | 58,897 | — | — | 36,459 | — | |
| Aug 17, 2026 AForm 4 → | Aug 19, 4:47 pm EDT | Amy E. HerrDirector | 1,381 | — | — | 1,381 | — | |
| Aug 17, 2026 AForm 4 → | Aug 19, 4:47 pm EDT | William GeistPRESIDENT, PROTEIN SCIENCES | 38,747 | — | — | 23,985 | — | |
| Aug 17, 2026 AForm 4 → | Aug 19, 4:46 pm EDT | Steven C. CrousePresident - Diag & Spatial Bi | 22,842 | — | — | 14,140 | — | |
| Aug 15, 2026 DMForm 4 → | Aug 18, 5:14 pm EDT | Kim KeldermanChief Executive Officer, Director | 85,337 | — | — | 23,569 | — | |
| Aug 15, 2026 DMForm 4 → | Aug 18, 5:13 pm EDT | James HippelCFO | 57,760 | — | — | 9,807 | — | |
| Aug 15, 2026 DMForm 4 → | Aug 18, 5:13 pm EDT | William GeistPRESIDENT, PROTEIN SCIENCES | 37,821 | — | — | 6,452 | — | |
| Aug 15, 2026 DMForm 4 → | Aug 18, 4:42 pm EDT | Shane BohnenSVP - General Counsel | 20,969 | — | — | 4,664 | — | |
| Aug 15, 2026 MForm 4 → | Aug 18, 4:13 pm EDT | Steven C. CrousePresident - Diag & Spatial Bi | 5,423 | — | — | 4,353 | — | |
| Aug 15, 2026 MForm 4 → | Aug 18, 4:12 pm EDT | Amy E. HerrDirector | 589 | — | — | 621 | — | |
| Jul 29, 2026 MForm 4 → | Jul 31, 5:18 pm EDT | James HippelCFO | 62,068 | — | — | 0 | — | |
| Jul 28, 2026 MForm 4 → | Jul 30, 4:11 pm EDT | Kim KeldermanChief Executive Officer, Director | 35,000 | — | — | 0 | — | |
| Jul 23, 2026 MForm 4 → | Jul 27, 4:03 pm EDT | Shane BohnenSVP - General Counsel | 448 | — | — | 0 | — | |
| Jun 2, 2026 MForm 4 → | Jun 4, 4:28 pm EDT | Steven C. CrousePresident - Diag & Spatial Bi | 600 | — | — | 1,200 | — | |
| Oct 25, 2018 AForm 4 → | Oct 29, 5:09 pm EDT | Randolph C SteerDirector | 1,898 | — | — | 1,898 | — | |
| Oct 25, 2018 AForm 4 → | Oct 29, 5:07 pm EDT | Alpna SethDirector | 1,898 | — | — | 1,898 | — | |
| Oct 25, 2018 AForm 4 → | Oct 29, 5:02 pm EDT | Harold J WiensDirector | 1,898 | — | — | 1,898 | — | |
| Oct 25, 2018 AForm 4 → | Oct 29, 5:00 pm EDT | Roeland NusseDirector | 1,898 | — | — | 1,898 | — | |
| Oct 25, 2018 AForm 4 → | Oct 29, 4:57 pm EDT | Joseph D KeeganDirector | 1,898 | — | — | 1,898 | — | |
| Oct 25, 2018 AForm 4 → | Oct 29, 4:54 pm EDT | John L HigginsDirector | 1,898 | — | — | 1,898 | — | |
| Oct 25, 2018 AForm 4 → | Oct 29, 4:51 pm EDT | Robert V BaumgartnerDirector | 1,898 | — | — | 1,898 | — | |
| Aug 24, 2018 MForm 4 → | Aug 28, 5:30 pm EDT | Robert V BaumgartnerDirector | 5,000 | — | — | 0 | — | |
| Aug 23, 2018 MForm 4 → | Aug 27, 4:12 pm EDT | John L HigginsDirector | 10,000 | — | — | 0 | — | |
| Aug 8, 2018 AForm 4 → | Aug 10, 4:28 pm EDT | Kim KeldermanPresident, Diagnostics & Genom | 22,768 | — | — | 9,033 | — | |
| Aug 8, 2018 MForm 4 → | Aug 10, 4:18 pm EDT | Charles A DinarelloDirector | 5,000 | — | — | 0 | — | |
| Aug 7, 2018 ADMForm 4 → | Aug 9, 7:22 pm EDT | Charles R. KummethChief Executive Officer, Director | 208,686 | — | — | 90,334 | — | |
| Aug 7, 2018 ADMForm 4 → | Aug 9, 6:29 pm EDT | Norman David EansorSVP - Novus Biologicals | 37,534 | — | — | 13,550 | — | |
| Aug 7, 2018 ADMForm 4 → | Aug 9, 6:26 pm EDT | Brenda S. FurlowSVP - General Counsel | 21,204 | — | — | 7,339 | — | |
| Aug 7, 2018 ADMForm 4 → | Aug 9, 6:19 pm EDT | James HippelChief Financial Officer | 52,300 | — | — | 18,066 | — | |
| May 1, 2018 AForm 4 → | May 3, 4:22 pm EDT | Kim KeldermanPresident, Diagnostics & Genom | 15,000 | — | — | 10,000 | — | |
| Feb 13, 2018 MForm 4 → | Feb 15, 4:02 pm EST | Charles A DinarelloDirector | 5,000 | — | — | 0 | — | |
| Nov 1, 2017 MForm 4 → | Nov 3, 4:41 pm EDT | Robert V BaumgartnerDirector | 5,000 | — | — | 0 | — | |
| Oct 26, 2017 AForm 4 → | Oct 31, 11:37 am EDT | Joseph D KeeganDirector | 3,125 | — | — | 3,125 | — | late |
| Oct 26, 2017 AForm 4 → | Oct 30, 5:16 pm EDT | Charles R. KummethChief Executive Officer, Director | 216,861 | — | — | 78,228 | — | |
| Oct 26, 2017 AForm 4 → | Oct 30, 5:14 pm EDT | Alpna SethDirector | 3,125 | — | — | 3,125 | — | |
| Oct 26, 2017 AForm 4 → | Oct 30, 5:10 pm EDT | Randolph C SteerDirector | 3,125 | — | — | 3,125 | — | |
| Oct 26, 2017 AForm 4 → | Oct 30, 5:08 pm EDT | J. Fernando BazanChief Technical Officer | 22,857 | — | — | 12,119 | — | |
| Oct 26, 2017 AForm 4 → | Oct 30, 5:03 pm EDT | Robert V BaumgartnerDirector | 3,125 | — | — | 3,125 | — | |
| Oct 26, 2017 AForm 4 → | Oct 30, 4:57 pm EDT | Brenda S. FurlowSVP - General Counsel | 23,897 | — | — | 12,670 | — | |
| Oct 26, 2017 AForm 4 → | Oct 30, 4:57 pm EDT | Robert M. GavinSen. VP Protein Platforms | 27,014 | — | — | 14,323 | — | |
| Oct 26, 2017 AForm 4 → | Oct 30, 4:56 pm EDT | Kevin S GouldSVP Clinical Controls | 27,014 | — | — | 14,323 | — | |
| Oct 26, 2017 AForm 4 → | Oct 30, 4:56 pm EDT | Norman David EansorSVP - Novus Biologicals | 30,132 | — | — | 15,976 | — | |
| Oct 26, 2017 AForm 4 → | Oct 30, 4:55 pm EDT | James HippelChief Financial Officer | 61,511 | — | — | 32,613 | — | |
| Oct 26, 2017 AForm 4 → | Oct 30, 4:54 pm EDT | John L HigginsDirector | 3,125 | — | — | 3,125 | — | |
| Oct 26, 2017 AForm 4 → | Oct 30, 4:53 pm EDT | Roeland NusseDirector | 3,125 | — | — | 3,125 | — | |
| Oct 26, 2017 AForm 4 → | Oct 30, 4:50 pm EDT | Harold J WiensDirector | 3,125 | — | — | 3,125 | — | |
| Oct 26, 2017 AForm 4 → | Oct 30, 4:46 pm EDT | Charles A DinarelloDirector | 3,125 | — | — | 3,125 | — | |
| Aug 12, 2017 AForm 4 → | Aug 15, 4:44 pm EDT | Charles R. KummethChief Executive Officer, Director | 66,849 | — | — | 66,849 | — | |
| May 26, 2017 MForm 4 → | May 31, 4:58 pm EDT | Charles A DinarelloDirector | 5,000 | — | — | 0 | — | |
| May 25, 2017 MForm 4 → | May 30, 4:34 pm EDT | Karen A HolbrookDirector | 5,000 | — | — | 0 | — | |
| Oct 27, 2016 AForm 4 → | Oct 31, 5:10 pm EDT | Roger C LucasDirector | 3,985 | — | — | 3,985 | — | |
| Oct 27, 2016 AForm 4 → | Oct 31, 4:55 pm EDT | Robert V BaumgartnerDirector | 3,985 | — | — | 3,985 | — | |
| Oct 27, 2016 AForm 4 → | Oct 31, 4:18 pm EDT | Harold J WiensDirector | 3,985 | — | — | 3,985 | — | |
| Oct 27, 2016 AForm 4 → | Oct 31, 4:17 pm EDT | Roeland NusseDirector | 3,985 | — | — | 3,985 | — | |
| Oct 27, 2016 AForm 4 → | Oct 31, 4:17 pm EDT | John L HigginsDirector | 3,985 | — | — | 3,985 | — | |
| Oct 27, 2016 AForm 4 → | Oct 31, 4:17 pm EDT | Karen A HolbrookDirector | 3,985 | — | — | 3,985 | — | |
| Oct 27, 2016 AForm 4 → | Oct 31, 4:16 pm EDT | Charles A DinarelloDirector | 3,985 | — | — | 3,985 | — | |
| Oct 27, 2016 AForm 4 → | Oct 31, 4:16 pm EDT | Randolph C SteerDirector | 3,985 | — | — | 3,985 | — | |
| Sep 1, 2016 MForm 4 → | Sep 6, 4:36 pm EDT | Robert V BaumgartnerDirector | 6,467 | — | — | 0 | — | |
| Aug 24, 2016 MForm 4 → | Aug 26, 5:38 pm EDT | Robert V BaumgartnerDirector | 3,533 | — | — | 1,467 | — | |
| Aug 18, 2016 ADMForm 4 → | Feb 3, 2017, 6:54 pm EST | Robert M. GavinSenior V.P. Protein Platforms | 67,510 | — | — | 2,111 | — | late |
| Aug 18, 2016 AForm 4 → | Aug 22, 5:14 pm EDT | J. Fernando BazanChief Technical Officer | 27,092 | — | — | 1,759 | — | |
| Aug 18, 2016 AForm 4 → | Aug 22, 5:13 pm EDT | Robert M. GavinSenior V.P. Protein Platforms | 32,510 | — | — | 2,111 | — | |
| Aug 18, 2016 AForm 4 → | Aug 22, 5:13 pm EDT | Kevin S GouldSVP Clinical Controls | 32,510 | — | — | 2,111 | — | |
| Aug 18, 2016 AForm 4 → | Aug 22, 5:13 pm EDT | Brenda S. FurlowSVP - General Counsel | 27,092 | — | — | 1,759 | — | |
| Aug 18, 2016 AForm 4 → | Aug 22, 5:12 pm EDT | Norman David EansorSVP - Biotech | 35,220 | — | — | 2,287 | — | |
| Aug 18, 2016 AForm 4 → | Aug 22, 5:12 pm EDT | James HippelChief Financial Officer | 75,858 | — | — | 4,925 | — | |
| Aug 18, 2016 AForm 4 → | Aug 22, 5:11 pm EDT | Charles R. KummethChief Executive Officer, Director | 281,927 | — | — | 24,979 | — | |
| May 5, 2016 MForm 4 → | May 9, 2:14 pm EDT | Charles A DinarelloDirector | 5,000 | — | — | 0 | — | |
| Mar 31, 2016 MForm 4 → | Apr 4, 2:57 pm EDT | James HippelChief Financial Officer | 1,666 | — | — | 1,667 | — | |
| Feb 5, 2016 MForm 4 → | Feb 8, 5:48 pm EST | Roger C LucasDirector | 5,000 | — | — | 0 | — | |
| Jan 4, 2016 AForm 4 → | Jan 6, 5:49 pm EST | Kevin S GouldSVP Clinical Controls | 10,000 | — | — | 10,000 | — | |
| Oct 29, 2015 AForm 4 → | Nov 2, 4:45 pm EST | Harold J WiensDirector | 4,260 | — | — | 4,260 | — | |
| Oct 29, 2015 AForm 4 → | Nov 2, 4:45 pm EST | Randolph C SteerDirector | 4,260 | — | — | 4,260 | — | |
| Oct 29, 2015 AForm 4 → | Nov 2, 4:44 pm EST | Roeland NusseDirector | 4,260 | — | — | 4,260 | — | |
| Oct 29, 2015 AForm 4 → | Nov 2, 4:44 pm EST | Roger C LucasDirector | 4,260 | — | — | 4,260 | — | |
| Oct 29, 2015 AForm 4 → | Nov 2, 4:43 pm EST | Karen A HolbrookDirector | 4,260 | — | — | 4,260 | — | |
| Oct 29, 2015 AForm 4 → | Nov 2, 4:43 pm EST | John L HigginsDirector | 4,260 | — | — | 4,260 | — | |
| Oct 29, 2015 AForm 4 → | Nov 2, 4:43 pm EST | Charles A DinarelloDirector | 4,260 | — | — | 4,260 | — | |
| Oct 29, 2015 AForm 4 → | Nov 2, 4:42 pm EST | Robert V BaumgartnerDirector | 4,260 | — | — | 4,260 | — | |
| Aug 17, 2015 MForm 4 → | Aug 19, 4:35 pm EDT | Roger C LucasDirector | 5,000 | — | — | 0 | — | |
| Aug 13, 2015 MForm 4 → | Aug 17, 4:32 pm EDT | Roger C LucasDirector | 5,000 | — | — | 0 | — | |
| Aug 7, 2015 AForm 4/A → | Aug 20, 6:43 pm EDT | Norman David EansorSVP - Novus Biologicals | 10,875 | — | — | 1,500 | — | |
| Aug 7, 2015 AForm 4 → | Aug 20, 6:10 pm EDT | Norman David EansorSVP - Novus Biologicals | 10,875 | — | — | 1,500 | — | late |
| Aug 7, 2015 AForm 4/A → | Aug 20, 6:09 pm EDT | Robert M. GavinSenior V.P. Protein Platforms | 10,875 | — | — | 1,500 | — | |
| Aug 7, 2015 AForm 4/A → | Aug 20, 6:08 pm EDT | Marcel VeronneauSVP - Clinical Controls | 6,525 | — | — | 900 | — | |
| Aug 7, 2015 AForm 4/A → | Aug 20, 6:08 pm EDT | Brenda S. FurlowSVP - General Counsel | 8,700 | — | — | 7,500 | — | |
| Aug 7, 2015 AForm 4/A → | Aug 20, 6:07 pm EDT | Charles R. KummethChief Executive Officer, Director | 136,558 | — | — | 17,283 | — | |
| Aug 7, 2015 AForm 4/A → | Aug 20, 6:06 pm EDT | J. Fernando BazanChief Technical Officer | 8,700 | — | — | 1,200 | — | |
| Aug 7, 2015 AForm 4/A → | Aug 20, 6:05 pm EDT | James HippelChief Financial Officer | 21,750 | — | — | 3,000 | — | |
| Aug 7, 2015 AForm 4 → | Aug 11, 4:44 pm EDT | Robert M. GavinSenior V.P. Protein Platforms | 19,750 | — | — | 1,000 | — | amended |
| Aug 7, 2015 AForm 4 → | Aug 11, 4:43 pm EDT | J. Fernando BazanChief Technical Officer | 15,800 | — | — | 800 | — | amended |
| Aug 7, 2015 AForm 4 → | Aug 11, 4:43 pm EDT | James HippelChief Financial Officer | 39,500 | — | — | 2,000 | — | amended |
| Aug 7, 2015 AForm 4 → | Aug 11, 4:41 pm EDT | Brenda S. FurlowSVP - General Counsel | 15,800 | — | — | 800 | — | amended |
| Aug 7, 2015 AForm 4 → | Aug 11, 4:40 pm EDT | Marcel VeronneauSVP - Clinical Controls | 11,850 | — | — | 600 | — | amended |
| Aug 7, 2015 AForm 4 → | Aug 11, 4:39 pm EDT | Norman David EansorSVP - Novus Biologicals | 19,750 | — | — | 1,000 | — | amended |
| Aug 7, 2015 AForm 4 → | Aug 11, 4:38 pm EDT | Charles R. KummethChief Executive Officer, Director | 170,556 | — | — | 11,522 | — | amended |